Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


25.02.2019

3 Alzheimers Dement
1 BMC Neurosci
1 Exp Gerontol
21 J Alzheimers Dis
2 J Biol Chem
1 J Neural Transm (Vienna)
1 Lancet Neurol
1 Neurobiol Aging
1 Neuropsychology
2 Neurosci Lett
1 Neuroscience
3 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. LANGBAUM JB, Karlawish J, Roberts JS, Wood EM, et al
    GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Alzheimers Dement. 2019 Feb 6. pii: S1552-5260(18)33624.
    PubMed     Text format     Abstract available

  2. WANG G, Coble D, McDade EM, Hassenstab J, et al
    Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Alzheimers Dement. 2019 Feb 14. pii: S1552-5260(18)33625.
    PubMed     Text format     Abstract available

  3. SANTOS OA, Pedraza O, Lucas JA, Duara R, et al
    Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.
    Alzheimers Dement. 2019 Feb 12. pii: S1552-5260(18)33630.
    PubMed     Text format     Abstract available


    BMC Neurosci

  4. AL-ATRACHE Z, Lopez DB, Hingley ST, Appelt DM, et al
    Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of beta-amyloid found in Alzheimer disease.
    BMC Neurosci. 2019;20:6.
    PubMed     Text format     Abstract available


    Exp Gerontol

  5. HAYASHI K, Hasegawa Y, Takemoto Y, Cao C, et al
    Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease.
    Exp Gerontol. 2019 Feb 17. pii: S0531-5565(18)30570.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  6. ONOJIGHOFIA TOBORE T
    On the Etiopathogenesis and Pathophysiology of Alzheimer's Disease: A Comprehensive Theoretical Review.
    J Alzheimers Dis. 2019 Feb 8. pii: JAD181052. doi: 10.3233/JAD-181052.
    PubMed     Text format     Abstract available

  7. FILSHTEIN TJ, Dugger BN, Jin LW, Olichney JM, et al
    Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180992. doi: 10.3233/JAD-180992.
    PubMed     Text format     Abstract available

  8. DAMULINA A, Pirpamer L, Seiler S, Benke T, et al
    White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180982. doi: 10.3233/JAD-180982.
    PubMed     Text format     Abstract available

  9. CONNER SC, Benayoun L, Himali JJ, Adams SL, et al
    Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180977. doi: 10.3233/JAD-180977.
    PubMed     Text format     Abstract available

  10. DECARLI C, Villeneuve S, Maillard P, Harvey D, et al
    Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180965. doi: 10.3233/JAD-180965.
    PubMed     Text format     Abstract available

  11. KASAHARA H, Ikeda M, Nagashima K, Fujita Y, et al
    Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180939. doi: 10.3233/JAD-180939.
    PubMed     Text format     Abstract available

  12. TAIPALE H, Lampela P, Koponen M, Tanskanen A, et al
    Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180912. doi: 10.3233/JAD-180912.
    PubMed     Text format     Abstract available

  13. DE LA MONTE SM, Tong M, Daiello LA, Ott BR, et al
    Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180906. doi: 10.3233/JAD-180906.
    PubMed     Text format     Abstract available

  14. DEVANARAYAN P, Devanarayan V, Llano DA
    Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research Framework.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180905. doi: 10.3233/JAD-180905.
    PubMed     Text format     Abstract available

  15. MARJANSKA M, McCarten JR, Hodges JS, Hemmy LS, et al
    Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180861. doi: 10.3233/JAD-180861.
    PubMed     Text format     Abstract available

  16. RODA AR, Montoliu-Gaya L, Villegas S
    The Role of Apolipoprotein E Isoforms in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180740. doi: 10.3233/JAD-180740.
    PubMed     Text format     Abstract available

  17. GUZMAN-MARTINEZ L, Tapia JP, Farias GA, Gonzalez A, et al
    The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180637. doi: 10.3233/JAD-180637.
    PubMed     Text format     Abstract available

  18. DEPCIUCH J, Zawlik I, Skrzypa M, Pajak J, et al
    FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD181008. doi: 10.3233/JAD-181008.
    PubMed     Text format     Abstract available

  19. BRUGNOLO A, De Carli F, Pagani M, Morbelli S, et al
    Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181022. doi: 10.3233/JAD-181022.
    PubMed     Text format     Abstract available

  20. ASHFORD JW
    Treatment of Alzheimer's Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions.
    J Alzheimers Dis. 2019;67:923-930.
    PubMed     Text format     Abstract available

  21. UNSWORTH CA, Russell K, Lovell R, Woodward M, et al
    Effect of Navigation Problems, Assessment Location, and a Practice Test on Driving Assessment Performance for People with Alzheimer's Disease.
    J Alzheimers Dis. 2019;67:1035-1043.
    PubMed     Text format     Abstract available

  22. SERRANO-POZO A, Growdon JH
    Is Alzheimer's Disease Risk Modifiable?
    J Alzheimers Dis. 2019;67:795-819.
    PubMed     Text format     Abstract available

  23. DING Y, Bao X, Lao L, Ling Y, et al
    p-Hydroxybenzyl Alcohol Prevents Memory Deficits by Increasing Neurotrophic Factors and Decreasing Inflammatory Factors in a Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019;67:1007-1019.
    PubMed     Text format     Abstract available

  24. MANDAL PK, Shukla D, Tripathi M, Ersland L, et al
    Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181054. doi: 10.3233/JAD-181054.
    PubMed     Text format     Abstract available

  25. HAN Z, Xue W, Tao L, Zhu F, et al
    Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181051. doi: 10.3233/JAD-181051.
    PubMed     Text format     Abstract available

  26. WANG X, Zimmermann HR, Ma T
    Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181043. doi: 10.3233/JAD-181043.
    PubMed     Text format     Abstract available


    J Biol Chem

  27. SMITH LM, Kostylev MA, Lee S, Strittmatter SM, et al
    Systematic and standardized comparison of reported Amyloid-beta receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    J Biol Chem. 2019 Feb 20. pii: RA118.006252. doi: 10.1074/jbc.RA118.006252.
    PubMed     Text format     Abstract available

  28. JEAN L, Brimijoin S, Vaux DJ
    In vivo localization of human acetylcholinesterase-derived species in a beta-sheet conformation at the core of senile plaques in Alzheimer's disease.
    J Biol Chem. 2019 Feb 20. pii: RA118.006230. doi: 10.1074/jbc.RA118.006230.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  29. ESCHER CM, Sannemann L, Jessen F
    Stress and Alzheimer's disease.
    J Neural Transm (Vienna). 2019 Feb 20. pii: 10.1007/s00702-019-01988.
    PubMed     Text format     Abstract available


    Lancet Neurol

  30. FRISONI GB, Jessen F
    One step towards dementia prevention.
    Lancet Neurol. 2018;17:294-295.
    PubMed     Text format    


    Neurobiol Aging

  31. JAFARI Z, Okuma M, Karem H, Mehla J, et al
    Prenatal noise stress aggravates cognitive decline and the onset and progression of beta amyloid pathology in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2019;77:66-86.
    PubMed     Text format     Abstract available


    Neuropsychology

  32. VENNERI A, Mitolo M, Beltrachini L, Varma S, et al
    Beyond episodic memory: Semantic processing as independent predictor of hippocampal/perirhinal volume in aging and mild cognitive impairment due to Alzheimer's disease.
    Neuropsychology. 2019 Feb 18. pii: 2019-08713-001. doi: 10.1037/neu0000534.
    PubMed     Text format     Abstract available


    Neurosci Lett

  33. FENG J, Dong L, Zhang J, Han X, et al
    Unique expression pattern of KIBRA in the enteric nervous system of APP/PS1 mice.
    Neurosci Lett. 2018;675:41-47.
    PubMed     Text format     Abstract available

  34. XU Y, Chen P, Wang X, Yao J, et al
    miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
    Neurosci Lett. 2018;670:94-104.
    PubMed     Text format     Abstract available


    Neuroscience

  35. AHN KC, Learman CR, Dunbar GL, Maiti P, et al
    Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
    Neuroscience. 2018;385:246-254.
    PubMed     Text format     Abstract available


    PLoS One

  36. JUNAID M, Islam N, Hossain MK, Ullah MO, et al
    Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
    PLoS One. 2019;14:e0211935.
    PubMed     Text format     Abstract available

  37. NGUYEN DT, Ryu S, Qureshi MNI, Choi M, et al
    Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer's dementia diagnosis using multi-measure rs-fMRI spatial patterns.
    PLoS One. 2019;14:e0212582.
    PubMed     Text format     Abstract available

  38. CAILLAUD M, Guillard J, Richard D, Milin S, et al
    Trans epsilon viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model.
    PLoS One. 2019;14:e0212663.
    PubMed     Text format     Abstract available


    Science

  39. NOBLE W, Spires-Jones TL
    Sleep well to slow Alzheimer's progression?
    Science. 2019;363:813-814.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: